ghk-cu dosage chart ghk cu peptide injection Dosage and Protocol: A Medical Provider's Guide to GHK-Cu Dosage: A Doctor's Guide

Proposed Mechanism BPC-157 appears to work through multiple pathways: Maintaining vesicular integrity (affecting VMATs and dopamine transporters) Possibly occupying its own vesicular storage sites Competing for dopamine receptor binding Functionally substituting when dopaminergic neurons are lost This last property, essentially filling in for missing dopamine function, would explain why the peptide counteracts both receptor agonists (apomorphine) and antagonists (haloperidol, fluphenazine, clozapine, sulpiride) with equal effectiveness

Pickart et al

Misconception: Topical GHK-Cu is as effective as injectable transdermal penetration of peptides is limited by molecular size (GHK-Cu = 340.84 Da, near the upper limit for passive diffusion)

Weeks 1 to 2: initial phase During the first two weeks, most users notice subtle improvements in skin hydration and texture